TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
897,719
|
989,720
|
907,295 |
| Financial expenses |
8,856
|
32,787
|
3,164 |
| Earnings before taxes |
-335,226
|
-60,490
|
3,063 |
| EBITDA |
-336,992
|
-10,046
|
16,302 |
| Total assets |
1,098,181
|
1,259,439
|
839,329 |
| Current assets |
508,102
|
716,730
|
607,262 |
| Current liabilities |
376,387
|
190,621
|
586,828 |
| Equity capital |
721,794
|
1,068,818
|
252,501 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
394
|
362
|
289 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.7%
|
84.9%
|
30.1% |
| Turnover per employee |
2,278
|
2,734
|
3,139 |
| Profit as a percentage of turnover |
-37.3%
|
-6.1%
|
0.3% |
| Return on assets (ROA) |
-29.7%
|
-2.2%
|
0.7% |
| Current ratio |
135.0%
|
376.0%
|
103.5% |
| Return on equity (ROE) |
-46.4%
|
-5.7%
|
1.2% |
| Change turnover |
-59,264
|
77,752
|
386,015 |
| Change turnover % |
-6%
|
9%
|
74% |
| Chg. No. of employees |
32
|
73
|
106 |
| Chg. No. of employees % |
9%
|
25%
|
58% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.